Lisa J. Christopher

1.1k total citations
41 papers, 897 citations indexed

About

Lisa J. Christopher is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Lisa J. Christopher has authored 41 papers receiving a total of 897 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 11 papers in Molecular Biology and 9 papers in Genetics. Recurrent topics in Lisa J. Christopher's work include Pharmacogenetics and Drug Metabolism (9 papers), Drug Transport and Resistance Mechanisms (9 papers) and Chronic Myeloid Leukemia Treatments (7 papers). Lisa J. Christopher is often cited by papers focused on Pharmacogenetics and Drug Metabolism (9 papers), Drug Transport and Resistance Mechanisms (9 papers) and Chronic Myeloid Leukemia Treatments (7 papers). Lisa J. Christopher collaborates with scholars based in United States, Germany and Sweden. Lisa J. Christopher's co-authors include W. Griffith Humphreys, Ramaswamy A. Iyer, David W. Boulton, Donghui Cui, Samuel J. Bonacorsi, Michael W. Lago, Mark E. Arnold, Kan He, Xiaohui Xu and Hong Shen and has published in prestigious journals such as Scientific Reports, Journal of Medicinal Chemistry and Journal of Pharmaceutical Sciences.

In The Last Decade

Lisa J. Christopher

40 papers receiving 861 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lisa J. Christopher United States	15	339	234	191	181	163	41	897
Ramaswamy A. Iyer United States	17	320 0.9×	277 1.2×	168 0.9×	190 1.0×	133 0.8×	49	992
Felix Waldmeier Switzerland	15	262 0.8×	264 1.1×	228 1.2×	107 0.6×	201 1.2×	25	1.1k
M Hroch Czechia	20	259 0.8×	198 0.8×	113 0.6×	129 0.7×	62 0.4×	70	1.0k
Meera Tugnait United States	14	308 0.9×	345 1.5×	77 0.4×	148 0.8×	105 0.6×	25	912
Céline Narjoz France	16	332 1.0×	311 1.3×	97 0.5×	250 1.4×	102 0.6×	42	1.1k
John Duan United States	12	297 0.9×	272 1.2×	252 1.3×	134 0.7×	184 1.1×	23	1.2k
Punit H. Marathe United States	15	220 0.6×	246 1.1×	93 0.5×	158 0.9×	66 0.4×	31	854
Sven Nylander Sweden	26	287 0.8×	431 1.8×	415 2.2×	75 0.4×	97 0.6×	52	2.6k
Anne M. Filppula Finland	17	345 1.0×	209 0.9×	108 0.6×	526 2.9×	55 0.3×	37	1.1k
Takenori Niioka Japan	20	320 0.9×	166 0.7×	146 0.8×	202 1.1×	101 0.6×	72	1.0k

Countries citing papers authored by Lisa J. Christopher

Since Specialization

Citations

This map shows the geographic impact of Lisa J. Christopher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa J. Christopher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa J. Christopher more than expected).

Fields of papers citing papers by Lisa J. Christopher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa J. Christopher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa J. Christopher. The network helps show where Lisa J. Christopher may publish in the future.

Co-authorship network of co-authors of Lisa J. Christopher

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa J. Christopher. A scholar is included among the top collaborators of Lisa J. Christopher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa J. Christopher. Lisa J. Christopher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Perera, Vidya, Zhaoqing Wang, Lisa J. Christopher, et al.. (2022). Effects of Itraconazole and Diltiazem on the Pharmacokinetics and Pharmacodynamics of Milvexian, A Factor XIa Inhibitor. Cardiology and Therapy. 11(3). 407–419. 18 indexed citations

Chang, Ming, Sai Praneeth Bathena, Lisa J. Christopher, Hong Shen, & Amit Roy. (2022). Prediction of drug–drug interaction potential mediated by transporters between dasatinib and metformin, pravastatin, and rosuvastatin using physiologically based pharmacokinetic modeling. Cancer Chemotherapy and Pharmacology. 89(3). 383–392. 9 indexed citations

Perera, Vidya, Zhaoqing Wang, Lisa J. Christopher, et al.. (2022). Effects of rifampin on the pharmacokinetics and pharmacodynamics of milvexian, a potent, selective, oral small molecule factor XIa inhibitor. Scientific Reports. 12(1). 22239–22239. 12 indexed citations

Shen, Hong, Lisa J. Christopher, Yurong Lai, et al.. (2018). Further Studies to Support the Use of Coproporphyrin I and III as Novel Clinical Biomarkers for Evaluating the Potential for Organic Anion Transporting Polypeptide 1B1 and OATP1B3 Inhibition. Drug Metabolism and Disposition. 46(8). 1075–1082. 50 indexed citations

Shen, Hong, Bridget L. Morse, Yue Zhao, et al.. (2015). Characterization of Organic Anion Transporter 2 (SLC22A7): A Highly Efficient Transporter for Creatinine and Species-Dependent Renal Tubular Expression. Drug Metabolism and Disposition. 43(7). 984–993. 72 indexed citations

Su, Hong, David W. Boulton, Lifei Wang, et al.. (2012). Characterization of the In Vitro and In Vivo Metabolism and Disposition and Cytochrome P450 Inhibition/Induction Profile of Saxagliptin in Human. Drug Metabolism and Disposition. 40(7). 1345–1356. 41 indexed citations

Xu, Xiaohui, Huidong Gu, Lisa J. Christopher, et al.. (2012). Liquid chromatography and tandem mass spectrometry method for the quantitative determination of saxagliptin and its major pharmacologically active 5-monohydroxy metabolite in human plasma: Method validation and overcoming specific and non-specific binding at low concentrations. Journal of Chromatography B. 889-890. 77–86. 32 indexed citations

Gong, Jiachang, Jinping Gan, Janet Caceres‐Cortes, et al.. (2011). Metabolism and Disposition of [14C]Brivanib Alaninate after Oral Administration to Rats, Monkeys, and Humans. Drug Metabolism and Disposition. 39(5). 891–903. 13 indexed citations

Hong, Haizheng, Hong Su, Li Ma, et al.. (2011). In Vitro Characterization of the Metabolic Pathways and Cytochrome P450 Inhibition and Induction Potential of BMS-690514, an ErbB/Vascular Endothelial Growth Factor Receptor Inhibitor. Drug Metabolism and Disposition. 39(9). 1658–1667. 10 indexed citations

10.

Marathe, Punit, Bogdan Sleczka, David Rodrigues, et al.. (2010). Preclinical Pharmacokinetics and In Vitro Metabolism of BMS-690514, a Potent Inhibitor of EGFR and VEGFR2. Journal of Pharmaceutical Sciences. 99(8). 3579–3593. 16 indexed citations

11.

Chando, Theodore J., et al.. (2010). Development and evaluation of a multiple-plate fraction collector for sample processing: Application to radioprofiling in drug metabolism studies. Journal of Pharmaceutical and Biomedical Analysis. 54(5). 979–986. 4 indexed citations

12.

Christopher, Lisa J., Haizheng Hong, Blisse Vakkalagadda, et al.. (2010). Metabolism and Disposition of [14C]BMS-690514, an ErbB/Vascular Endothelial Growth Factor Receptor Inhibitor, after Oral Administration to Humans. Drug Metabolism and Disposition. 38(11). 2049–2059. 16 indexed citations

13.

Hong, Haizheng, Hong Su, Alban J. Allentoff, et al.. (2010). Metabolism and Disposition of [14C]BMS-690514 after Oral Administration to Rats, Rabbits, and Dogs. Drug Metabolism and Disposition. 38(7). 1189–1201. 4 indexed citations

14.

Fura, Aberra, Ashish K. Khanna, Viral Vyas, et al.. (2009). Pharmacokinetics of the Dipeptidyl Peptidase 4 Inhibitor Saxagliptin in Rats, Dogs, and Monkeys and Clinical Projections. Drug Metabolism and Disposition. 37(6). 1164–1171. 86 indexed citations

15.

He, Kan, et al.. (2008). Lacteal Secretion, Fetal and Maternal Tissue Distribution of Dasatinib in Rats. Drug Metabolism and Disposition. 36(12). 2564–2570. 43 indexed citations

16.

Christopher, Lisa J., Donghui Cui, Chi‐Yuan Wu, et al.. (2008). Metabolism and Disposition of Dasatinib after Oral Administration to Humans. Drug Metabolism and Disposition. 36(7). 1357–1364. 158 indexed citations

17.

Wang, Lifei, Lisa J. Christopher, Donghui Cui, et al.. (2008). Identification of the Human Enzymes Involved in the Oxidative Metabolism of Dasatinib: An Effective Approach for Determining Metabolite Formation Kinetics. Drug Metabolism and Disposition. 36(9). 1828–1839. 58 indexed citations

18.

Raghavan, Nirmala, Donglu Zhang, Mingshe Zhu, Jianing Zeng, & Lisa J. Christopher. (2004). CYP2D6 CATALYZES 5-HYDROXYLATION OF 1-(2-PYRIMIDINYL)-PIPERAZINE, AN ACTIVE METABOLITE OF SEVERAL PSYCHOACTIVE DRUGS, IN HUMAN LIVER MICROSOMES. Drug Metabolism and Disposition. 33(2). 203–208. 9 indexed citations

19.

Bello, Akintunde, et al.. (2002). Effect of a High‐Fat Meal on the Pharmacokinetics of the Des‐F(6)‐Quinolone BMS‐284756. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 22(2). 160–165. 11 indexed citations

20.

Kerrigan, John E., et al.. (2000). 6-Acylamino-2-[(alkylsulfonyl)oxy]-1H-isoindole-1,3-dione mechanism-based inhibitors of human leukocyte elastase. Bioorganic & Medicinal Chemistry Letters. 10(1). 27–30. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact